ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Altimmune, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.23+0.03 (+1.36%)
Close on Oct 19, 2026
- Market cap
- $413.54M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Altimmune has not reported a dividend
No dividend per share appears in Altimmune's annual filings since fiscal 2010.